In vitro platination of human breast cancer suppressor gene1 (BRCA1) by the anticancer drug carboplatin-Reference-Cited by-同舟云学术

In vitro platination of human breast cancer suppressor gene1 (BRCA1) by the anticancer drug carboplatin

Published:2005-09 Issue:2 Volume:1725 Page:145-151
ISSN:0304-4165
Container-title:Biochimica et Biophysica Acta (BBA) - General Subjects
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - General Subjects

Author:

Ratanaphan Adisorn,Canyuk Bhutorn,Wasiksiri Siriwat,Mahasawat Pawika

Publisher

Elsevier BV

Subject

Molecular Biology,Biochemistry,Biophysics

Reference38 articles.

1. Interaction of platinum antitumor compounds with DNA;Lepre,1990

2. Improved understanding in platinum antitumour chemistry;Reedijk;Chem. Commun.,1996

3. Adducts of the antitumor drug cis-diamminedichloroplatinum (II) with DNA: formation, identification and quantitation;Fichtinger-Schepman;Biochemistry,1985

4. Induction and repair of DNA cross-links in CHO cells treated with various platinum coordination compounds in relation to platinum binding to DNA, cytotoxicity, mutagenicity and antitumor activity;Plooy;Cancer Res.,1984

5. Characterization of a DNA damage-recognition protein from mammalian cells that binds specifically to intrastrand d(GpG) and d(ApG) DNA adducts of the anticancer drug cisplatin;Donahue;Biochemistry,1990

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA binding and cleavage, BRCA1 gene interaction, antiglycation and anticancer studies of transition metal complexes of sulfonamides;Molecular Diversity;2022-02-19

2. Thymic Immunosuppressive Pentapeptide (TIPP) Shown Anticancer Activity in Breast Cancer and Chronic Myeloid Leukemia Both In Vitro and In Vivo;Protein & Peptide Letters;2021-10

3. Newly synthesized metal complexes of sulfonamides: DNA cleavage, BRCA1 gene interaction, expression analysis, antioxidant and antiglycation studies;Chemical Papers;2021-09-23

4. Anticancer activity of RAPTA-EA1 in triple-negative BRCA1 proficient breast cancer cells: single and combined treatment with the PARP inhibitor olaparib;Heliyon;2021-08

5. Cellular responses of BRCA1-defective HCC1937 breast cancer cells induced by the antimetastasis ruthenium(II) arene compound RAPTA-T;Apoptosis;2019-04-23